UK markets close in 2 hours

Olink Holding AB (publ) (OLK)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
24.87+0.34 (+1.39%)
As of 9:30AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close24.53
Bid24.00 x 800
Ask199,999.98 x 800
Day's range24.87 - 24.87
52-week range24.43 - 42.20
Avg. volume294,387
Market cap2.96B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.37
Earnings date11 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est43.00
  • Globe Newswire

    Olink to present at two upcoming investor conferences

    UPPSALA, Sweden, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Jon Heimer, CEO, and Oskar Hjelm, CFO, will participate in the following virtual investor conferences: Goldman Sachs Eighteenth Annual European Medtech and Healthcare Services ConferenceFireside chat on Wednesday, September 8th at 10:30 a.m. ET Morgan Stanley 19th Annual Global Healthcare ConferenceFireside chat on Friday, September 10th at 8:00 a.m. ET Live and archived webc

  • Globe Newswire

    CellCarta expands its biomarker capabilities for clinical trials by adding Olink technology to its global services

    UPPSALA, Sweden, Aug. 31, 2021 (GLOBE NEWSWIRE) -- CellCarta and Olink Proteomics AB announced today a strategic collaboration to offer Olink® Target 96 & Target 48 to pharmaceutical and biotech customers, advancing targeted protein biomarker quantification in clinical studies. CellCarta is a global leader in precision medicine and with more than 20 years of experience in mass spectrometry the company continues to invest in the field of proteomic biomarkers to better understand diseases and supp

  • Globe Newswire

    Olink reports second quarter 2021 financial results

    UPPSALA, Sweden, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its financial results for the second quarter of 2021. Highlights: Revenue was $17.7 million in the second quarter of 2021, representing year over year growth of 124% on a reported basis and 129% on a constant currency adjusted like-for-like basisAdjusted EBITDA was ($6.3) million in the second quarter of 2021, as compared to ($1.3) million in the second quarter of 2020Net loss was (